Stay updated with breaking news from Oncogenic Drivers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10.04.2024 - Extended the Strategic Collaboration with Gilead Sciences Extended the Strategic Collaboration with Sanofi to Develop Novel Orally Available Targeted Protein Degrader of STAT6 Presented new case studies on NX-5948 demonstrating clinical responses ...
The vast variety of tumors makes each cancer a world. For researchers, understanding the commonalities and divergences in their molecular underpinnings could help find successful treatments. Scientists from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) have addressed these similarities and differences in 10 different types of cancer with two proteogenomic studies to unravel the genes that lead to cancer and the galaxy of interactions that regulate them.
/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) and the EGFR Resisters, in their second year of a research award partnership, announce the 2022...
In Second Year of Partnership, Groups Select and Fund Three ProjectsNEW YORK, Dec. 8, 2022 /PRNewswire/ -- The Lung Cancer Research Foundation (LC...
/PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) is pleased to announce the awardees of its 2022 Scientific Grant Program. This years' grant cycle...